As of Mar 23
| +0.83 / +0.89%|
The 21 analysts offering 12-month price forecasts for Edwards Lifesciences Corp have a median target of 120.00, with a high estimate of 140.00 and a low estimate of 80.00. The median estimate represents a +27.25% increase from the last price of 94.30.
The current consensus among 27 polled investment analysts is to Buy stock in Edwards Lifesciences Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.